*There is a fair possibility of HBL securing a portion of the 10k tender, also noted that FII/DII have increased their holdings in the last quarter
Disc: invested.
*There is a fair possibility of HBL securing a portion of the 10k tender, also noted that FII/DII have increased their holdings in the last quarter
Disc: invested.
DCGI has recently granted permission for the manufacturing and marketing of “Cefepime+Enmetazobactam” - for a NCE manufactured by Orchid Pharma.
The use case of this drug is similar to that of WCK 5222. “treatment of complicated Urinary Tract Infections (cUTI) including acute Pyelonephritis, HospitalAcquired Pneumonia (HAP) including Ventilator-associated pneumonia (VAP), and Bacteremia when it is associated or suspected to be associated with either complicated urinary tract
infections or hospital-acquired pneumonia”
Cefepime+Zidebactam was found out to be more potent than Cefepime+Enmetazobactam as per Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales - PMC)
How would this affect the market for WCK 5222? Will a competitor launching a similar product earlt (albeit less potent/efficient) change the pricing strategy of Wockhardt? What if this product gains distribution before WCK 5222 is released? Would love to know your thoughts on this. Disc: Invested
Thanks
@adminph2
Dear admin,
please ask the above 2 members to take their quarrel to private messages. They are cluttering a public thread in their feud.
Please also delete this and the quarrelling messages above at your discretion.
If you can buy multiple lots than can take entry in 1 and rest on dips
If only 1 lot than exact timing can be difficult
But can wait for retest ( if it happens ) as it is large base breakout
Where did I said they never sold shares.
I said they are not Offloading which means continuous selling .
Take grammar lessons !
This was your revert before that.
Anyway, I don’t have all day or days to spend on the issue.
Stay blessed and goodbye
Still no data only opinion.
I am done talking with you.
Incase you have problems understanding the simplest forms of sentences, you must go ahead and read again.
I asked does this company fall into brackets of bcgs, vakrangees and manpasanda, I was looking for information and opinions, you took that comment or query offensive.
And the point is their(promoter) shareholding is reducing , and price action is fishy obviously any sane mind would wanna gather information about that, unless one is naive and emotionally hooked up to his investment ideology, and refuses to look at what’s is obvious and publically known.
U initially stated that promoter has never sold, now you’re stating they sold some qty in March.
Well be it that, I wouldn’t have faith in promoter who sells at disimal pricing ( holding of his own firm)
Now your case is different u wanna find it comforting, that’s your call.
And lastly u made some personal remark, about how I should be elsewhere, I’m not one to decide or judge what u must do or not do with ur investment journey or profession and I’d hope the same level of decency and respect from others.
I was looking to add a defense stock to my portfolio and CFF looks interesting from a Market Cap and high Roe/Roce perspective. However the recent run up hints at a near time correction to me.
Any advice on how to proceed?
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!